Number and proportion of glaucoma patients continuing with their first-line therapy after 1, 3, and 5 years of follow-up in the FinHealth 2017 Survey sample representing the Finnish adult population aged 30 years or older according to their first-line glaucoma monotherapy drug class and type during the follow-up between 1995 and 2019.

<p>Number and proportion of glaucoma patients continuing with their first-line therapy after 1, 3, and 5 years of follow-up in the FinHealth 2017 Survey sample representing the Finnish adult population aged 30 years or older according to their first-line glaucoma monotherapy drug class and typ...

Full description

Saved in:

Bibliographic Details
Main Author:	Petri K. M. Purola (17684370) (author)
Other Authors:	Seppo V. P. Koskinen (17684379) (author), Hannu M. T. Uusitalo (17684382) (author)
Published:	2025
Subjects:	Medicine Neuroscience Biotechnology Developmental Biology Cancer Infectious Diseases Environmental Sciences not elsewhere classified topical drug therapy linked register data 1995 &# 8211 line glaucoma therapy glaucoma drug monotherapy survey participants based based cohort study line glaucoma monotherapy random sample drawn prostaglandin analogues compared long initial therapies line glaucoma medication 141 glaucoma patients 3 patients continuing line monotherapy glaucoma medication prostaglandin analogues glaucoma patients patients continuing 2019 based nationwide survey cohort (< 3 years xlink "> well established timolol fixed special reimbursements n </ included prescriptions healthcare systems consistent problem 5 years
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items